Emergent BioSolutions to Acquire PaxVax from Cerberus Capital Management
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.23 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.23 | 52 Week High | $44.38 | |||
| Open | $6.20 | 52 Week Low | $24.47 | |||
| Day High | $6.25 | P/E | 311.50 | |||
| Day Low | $6.01 | EPS | $0.02 | |||
| Volume | 727,337 | |||||
